Staying abreast of new technology and diagnostic as well as treatment options for our patients is a high priority at Baylor Scott & White Heart and Vascular Hospital. Our goal is to develop and be involved in advanced research of the highest integrity that will allow our patients to participate in and benefit from innovative heart and vascular discoveries. Research is the backbone and first step in defining patient care. The 75-plus trials we are currently running are investigating many areas, including an anticoagulant that does not require INR bloodwork, genes and angina, atrial fibrillation, and stenting of the left main coronary artery.
The physicians on our medical staff and clinical staff members have been published in numerous journals and books, on topics ranging from atrial septal defects to congestive heart failure to angiography. Recent articles are included below:
Fathima S, Hall SA, Grayburn PA, Roberts WC. The Mitral Valve 16 Months After Operative Insertion of the Alfieri Stitch. American Journal of Cardiology 2019; In Press.
Fathima S, Roberts WC. Comparison of Clinical and Morphologic Findings in Patients with Cardiac Sarcoidosis Severe Enough to Warrant Heart Transplantation in Those With – vs – Those Without Non-Caseating Granulomas in the Explanted Heart (Burnt-Out Sarcoid). American Journal of Cardiology 2019; In Press.
Filardo G, Ailawadi G, Pollock BD, da Graca B, Phan TK, Thourani V, Damiano RJ Jr. Postoperative Atrial Fibrillation: Sex-Specific Characteristics and Effect on Survival. Journal of Thoracic and Cardiovascular Surgery 2019; In Press.
Giustino G, Overbey J, Taylor D, Ailawadi G, Kirkwood K, DeRose J, Gillinov MA, Dagenais F, Mayer ML, Moskowitz A, Bagiella E, Miller M, Grayburn P, Smith PK, Geligns A, O’Gara P, Acker M, Lala A, Hung J. Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials Network. JACC: Heart Failure June 2019; 7(6): 481-490.
Guerrero-Miranda CY, Hall SA. Cardiac catheterization and percutaneous intervention procedures on extracorporeal membrane oxygenation support. Annals of Cardiothoracic Surgery Jan 2019; 8(1): 123-128.
Hamandi M, Smith RL, Ryan WH, Grayburn PA, Vasudevan A, George TJ, DiMaio JM, Hutcheson KA, Brinkman W, Szerlip M, Moore DO, Mack MJ. Outcomes of Isolated Tricuspid Valve Surgery Have Improved in the Modern Era. Annals of Thoracic Surgery July 2019; 108(1): 11-15.
Harmon DM, Tecson KM, Jamil AK, Felius J, Gonzalez-Stawinski GV, Joseph SM, Hall SA. Outcomes of orthotopic heart transplantation and left ventricular assist device in patients aged 65 years or more with end-stage heart failure. Baylor University Medical Center Proceedings April 2019; 32(2): 177-180.
Harmon DM, Tecson KM, Lima B, Collier JDG, Shaikh AF, Still S, Baxter RD, Lew N, Thakur R, Felius J, Hall SA, Gonzalez-Stawinski GV, Joseph SM. Outcomes of Moderate-to-Severe Acute Kidney Injury following Left Ventricular Assist Device Implantation. CardioRenal Medicine Feb 2019; 9(2): 100-107.
Jacob S, Lima B, Gonzalez-Stawinski GV, El-Sayed Ahmed MM, Patel PC, Belli EV, Markey IA, Thomas M, Landolfo K, Landolfo C, Leoni Moreno JC, Yip BS, Pham SM. Extracorporeal Membrane Oxygenation as a Salvage Therapy for Patients with Severe Primary Graft Dysfunction After Heart Transplant. Clinical Transplantation May 2019; 33(5): e13538.
Khush KK, Patel J, Pinney S, Kao A, Alharethi R, DePasquale E, Ewald G, Berman P, Kanwar M, Hiller D, Yee JP, Woodward RN, Hall S, Kobashigawa J. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study. American Journal of Transplantation 2019; In Press.
Lee AY, Tecson KM, Lima B, Shaikh AF, Collier J, Still S, Baxter R, DiMaio JM, Felius J, Carey SA, Gonzalez-Stawinski GV, Nauret R, Wong M, Hall SA, Joseph SM. Durable Left Ventricular Assist Device Implantation in Extremely Obese Heart Failure Patients. Artificial Organs March 2019; 43(3): 234-241.
Roberts WC, Jameson LC, Bahmani A, Roberts CS, Rafael AE, Hall SA. Morphological and Functional Characteristics of the Right Ventricle Functioning as a Systemic Ventricle for Decades After an Atrial Switch Procedure for Complete Transposition of the Great Arteries. The American Journal of Cardiology June 2019; 123(11): 1863-1867.
Roberts WC, Lee AY, Lander SR, Roberts CS, Hamman BL. Libman-Sacks Endocarditis Involving a Bioprosthesis in the Aortic Valve Position in Systemic Lupus Erythematosus. American Journal of Cardiology July 2019; 124(2): 316-318.
Thakkar SJ, Grayburn PA, Hall SA, Roberts WC. Orthotopic Heart Transplantation for Ankylosing Spondylitis Masquerading as Nonischemic Cardiomyopathy. American Journal of Cardiology May 2019; 123(10): 1732-1735.
Carey SA, Tecson KM, Jamil AK, Felius J, Wolf-Doty TK, Hall SA. Gene expression profiling scores in dual organ transplant patients are similar to those in heart-only recipients. Transplant Immunology Mar 2018; In Press.
Felius J, Hall SA. Employment status at the time of heart transplant listing. Journal of Heart and Lung Transplantation May 2018; 37(5): 575-576.
Filardo G, Hamman BL, da Graca B, Sass DM, Machala NJ, Ismail S, Pollock BD, Collinsworth AW, Grayburn PA. Efficacy and effectiveness of on- versus off-pump coronary artery bypass grafting: A meta-analysis of mortality and survival. Despite many studies comparing on- versus off-pump coronary artery bypass graft (CABG), there is no consensus as to whether one of these techniques offers patients better outcomes.
Gong TA, Joseph SM, Lima B, Gonzalez-Stawinski GV, Jamil AK, Felius J, Qin H, Saracino G, Rafael AE, Kale P, Hall SA. Donor predicted heart mass as predictor of primary graft dysfunction. Journal of Heart and Lung Transplantation July 2018; 37(7): 826-835.
Himmelfarb J, Chertow GM, McCullough PA, Mesana T, Shaw AD, Sundt TM, Brown C, Cortville D, Dagenais F, de Varennes B, Fontes M, Rossert J, Tardif JC. Perioperative THR-184 and AKI after Cardiac Surgery. Journal of the American Society of Nephrology Feb 2018; 29(2): 670-679.
Howard CE, Velasco CE, Roullard CP. Rafael A. Aorto-right atrial fistula after Bentall repair. Proceedings Baylor University Medical Center. July 2017;30(3).
Lima B, Bansal A, Abraham J, Rich JD, Lee SS, Soleimani B, Katz JN, Young JS, Patel CB, Joseph SM, Evolving Mechanical Support Research Group (EMERG). Controversies and Challenges of Ventricular Assist Device Therapy. American Journal of Cardiology May 2018; 121(10): 1219-1224.
Lima B, Dur O, Chuang J, Chamogeorgakis T, Farrar DJ, Sundareswaran KS, Felius J, Joseph SM, Hall SA, Gonzalez-Stawinski GV. Novel Cardiac Coordinate Modeling System for Three-Dimensional Quantification of Inflow Cannula Malposition of HeartMate II LVADs. Optimal function of left ventricular assist devices (LVADs) depends on proper alignment of the inflow cannula (IC). Quantitative guidelines for IC angulation are lacking because of variation in cardiac geometry and difficulty in analyzing three-dimensional (3D) cannula orientation relative to the left ventricle (LV). Based on contrast-enhanced computed tomography images from five normal and five clinically malpositioned IC cases in patients with HeartMate II LVADs, we developed a method for 3D quantification of IC malpositioning. Using Mimics image software (Materialise, Leuven, Belgium), the native heart, major arteries, and LVAD were segmented to create patient-specific 3D models, allowing LV cavity volume and long-axis length to be measured directly. The deviation of the IC was quantified in a cylindrical coordinate system at the IC insertion point relative to the mitral valve and septum, and IC occlusion was assessed by the distance between cannula inlet and the proximal endocardium. Compared with normal cases, patients with malpositioned pumps had shorter LV length (p = 0.03) and reduced pump pocket depth (p = 0.009). Malpositioned pumps may experience greater obstruction by the nearby myocardium. This quantitative 3D modeling tool may help identify different modes of pump malalignment and migration and may facilitate preoperative planning and minimally invasive approaches via virtual LVAD implantation.
Steimer DA, Hernandez O, Mason DP, Schwartz GS. Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDS. Thoracic and Cardiovascular Surgeon May 2018; Epub.
Still S, Shaikh AF, Qin H, Felius J, Jamil AK, Saracino G, Chamogeorgakis T, Rafael AE, MacHannaford JC, Joseph SM, Hall SA, Gonzalez-Stawinski GV, Lima B. Reoperative sternotomy is associated with primary graft dysfunction following heart transplantation. Interactive Cardiovascular and Thoracic Surgery March 2018; Epub.
Squiers JJ, DiMaio JM, Sarcino G, Qin H, Felius J, Chamogeorgakis T, MacHannaford JC, Rafael AE, Kale P, Joseph SM, Hall SA, Gonzalez-Stawinski GV, Lima B. Utilization of high donor sequence number grafts in cardiac transplantation. Donor sequence number (DSN) represents the number of candidates to whom a graft was offered and declined prior to acceptance for transplantation. We sought to investigate the outcomes of patients receiving high DSN grafts. Consecutive isolated adult cardiac transplantations performed at a single-center were reviewed. Recipients were grouped into standard (?75th percentile) DSN and high (>75th percentile) DSN. A previously validated donor risk index was used to quantify the risk associated with donor grafts, and recipient outcomes were assessed. Overall, 254 patients were included: 194 standard DSN (range 1-79) and 60 high DSN (range 82-1723). High DSN grafts were harvested at greater distance (P < .001) with increased ischemia time (P < .001), resulting in a modest increase in donor risk index (1 point median difference, P=. 014). High DSN recipients were less frequently listed as UNOS status 1A (P < .001). Despite a nonsignificant trend toward increased in-hospital/30-day mortality in high DSN recipients, there were no differences in primary graft dysfunction or 1-year survival (high DSN 89% vs standard DSN 88%, P=. 82). After adjustment for risk factors, high DSN was not associated with increased 1-year mortality (hazard ratio 1.18, 95%-CI 0.54-2.58, P=. 68).
Tecson KM, Brown D, Choi JW, Feghali G, Gonzalez-Stawinski GV, Hamman BL, Hebeler R, Lander SR, Lima B, Potluri S, Schussler JM, Stoler RC, Velasco C, McCullough PA. Major Adverse Renal and Cardiac Events Following Angiography and Cardiac Surgery.Patients at high risk for developing post-procedural complications may receive iodixanol, an iso-osmolar contrast, during coronary angiography to minimize the risk of renal toxicity. For those who additionally require cardiac surgery, the wait-time between angiography and surgery may be a modifiable factor capable of mitigating poor surgical outcomes; however, there have been inconsistsent reports regarding the optimal wait-time. We sought to determine the effects of wait time between angiogram and cardiac surgery, as well as contrast induced acute injury (CI-AKI) on the development of major adverse renal and cardiac events (MARCE).
Tecson KM, Lima B, Lee AY, Ching G, Lee CH, Felius J, Baxter RD, Still S, Collier JDG, Hall SA, Joseph SM. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation. Journal of American Heart Association May 2018; 7(11): e008377.
Velasco CE, Hashemi H, Roullard CP, MacHannaford J, Roberts WC. Asymptomatic Ascending Aorta Aneurysm with Severe Aortic Regurgitation Caused by Multiple Intimal-Medial Tears Unassociated with Aortic Dissection. A 62-year-old man was found to have an asymptomatic ascending aortic aneurysm (6.6?cm) associated with severe aortic regurgitation. Operative resection of the wall of the aneurysm disclosed its cause to be multiple healed intimal-medial tears without dissection involving a previously normal aorta. The concept of an intimal-medial tear unassociated with aortic dissection is a poorly recognized entity and these tears appear to be asymptomatic and after the aortic tearing lead to aneurysmal formation.
Baumgarten H, Squiers JJ, Brinkman BT, Vasquez J. Endovascular Technique for Repair of Descending Thoracic Aortic Aneurysm After Coarctation Operation. The Annals of Thoracic Surgery Feb 2017; 103(2):e167-e169.
Edgerton JR, Herbert MA, Hamman BL, Ring WS.
Readmission rates after cardiac surgery are being used as a quality indicator; they are also being collected by Medicare and are tied to reimbursement. Accurate knowledge of readmission rates may be difficult to achieve because patients may be readmitted to different hospitals. In our area, 81 hospitals share administrative claims data; 28 of these hospitals (from 5 different hospital systems) do cardiac surgery and share Society of Thoracic Surgeons (STS) clinical data. We used these 2 sources to compare the readmissions data for accuracy.
Jamil A, Qin H, Felius J, Saracino G, Rafael AE, MacHannaford JC, Gonzalez-Stawinski GV, Lima B.
Advanced recipient age remains a limiting factor for heart transplant candidacy, with many centers reluctant to transplant older patients. Here, we report our experience with recipients aged ?65 years compared with younger recipients in terms of baseline characteristics, intraoperative and immediate postoperative experiences, and post-transplant morbidity and survival. The main study outcome was primary graft dysfunction (PGD), which has not been widely studied in this population. Donor and recipient data from 255 heart transplantations performed between 2012 and 2016 were reviewed. Seventy (27%) recipients were ?65 years and 185 were younger. The older group had a higher frequency of ischemic cardiomyopathy and more frequently had a previous sternotomy than the younger recipients (all p?<0.007). We found no significant differences in post-transplant morbidity (intensive care unit and hospital stay, pneumonia, infections, reoperation for bleeding, stroke, renal failure, or in-hospital mortality; all p?>0.12). One-year survival was also similar in the 2 groups (p?=?0.88). The incidence of moderate or severe PGD was lower in the older group (6%) than in the younger group (16%; p?=?0.037). Multivariate logistic regression found pretransplant creatinine and donor undersizing by predicted heart mass to be predictors of moderate to severe PGD, whereas recipient age ?65 years was identified as protective against PGD in this cohort. In conclusion, our study showed comparable survival and outcomes in recipients ?65 years of age with otherwise similar nutritional status and body mass composition.
Joseph SM, Manghelli JL, Vader JM, Keeney T, Novak EL, Felius J, Martinez SC, Nassif ME, Lima B, Silvestry SC, Rich MW.
Frail patients are more prone to adverse events after cardiac surgery, particularly after implantation of left ventricular assist devices. Thus, frailty assessment may help identify patients unlikely to benefit from left ventricular assist device therapy. The purpose was to establish a suitable measure of frailty in adults with end-stage heart failure. In a prospective cohort of 75 patients (age 58?±?12 years) with end-stage heart failure, we assessed the association between frailty (5-component Fried criteria) and the composite primary outcome of inpatient mortality or prolonged length of stay, as well as extubation status, time on ventilator, discharge status, and long-term mortality. Fried frailty criteria were met in 44 (59%) patients, but there was no association with the primary outcome (p?=?0.10). However, an abridged set of 3 criteria (exhaustion, inactivity, and grip strength) was predictive of the primary outcome (odds ratio 2.9, 95% confidence interval 1.1 to 7.4), and of time to extubation and time to discharge. In patients with advanced heart failure, the 5-component Fried criteria may not be optimally sensitive to clinical differences. In conclusion, an abridged set of 3 frailty criteria was predictive of the primary outcome and several secondary outcomes, and may therefore be a clinically useful tool in this population.
Ring WS, Edgerton JR, Herbert M, Prince S, Knoff C, Jenkins KM, Jessen ME, Hamman BL.
Risk-adjusted operative mortality is the most important quality metric in cardiac surgery for determining The Society of Thoracic Surgeons (STS) Composite Score for star ratings. Accurate 30-day status is required to determine STS operative mortality. The goal of this study was to determine the effect of unknown or missing 30-day status on risk-adjusted operative mortality in a regional STS Adult Cardiac Surgery Database cooperative and demonstrate the ability to correct these deficiencies by matching with an administrative database.
Sannino A, Stoler RC, Hebeler RF, Szlerip M, Mack MJ, Grayburn PA.
Significant thrombocytopenia (TCP) commonly occurs in seriously ill patients and after open-heart surgery, possibly as a result of cardiopulmonary bypass, use of intraaortic balloon counterpulsation, sepsis, and post-transfusion purpura. However, even severe TCP has not been clearly linked to a significant worsening in outcomes after surgical aortic valve replacement (SAVR). Transcatheter aortic valve replacement (TAVR) is the standard of care in high-risk and intermediate-risk patients with symptomatic severe aortic stenosis (AS). Current evidence suggests that acquired TCP occurring after TAVR may be due to thienopyridine use and extracorporeal circulatory support, and may be associated with adverse outcomes. However, few data exist regarding clinical outcomes associated with baseline TCP in patients undergoing TAVR. In a single small study, moderate-severe TCP was not associated with mortality, although the study was underpowered. Given that TAVR is most often performed in elderly subjects, many of whom are also frail and have baseline TCP, the aim of this study was to evaluate the effect of baseline TCP on clinical outcomes after TAVR.
Shaikh AF, Joseph SM, Lima B, Hall SA, Malyala R, Rafael AE, Gonzalez-Stawinski GV, Chamogeorgakis T.
Left ventricular assist devices (LVADs) have revolutionized the treatment of patients with end-stage heart failure. These devices are replaced when pump complications arise if heart transplant is not possible. We present our experience with HeartMate II (HMII (Thoratec, Plesanton, California, United States)) LVAD pump exchange.
Gottlieb RL, Sam T, Wada SY, Trotter JF, Asrani SK, Lima B, Joseph SM, Gonzalez-Stawinski GV, Hall SA. Hearts from donors with hepatitis C virus (HCV) are underutilized for orthotopic heart transplantation (HT) owing to post-transplantation risks, including increased recipient mortality and coronary allograft vasculopathy. New highly effective direct-acting antiviral agents (DAAs) that target multiple steps in the HCV replication life cycle could transform cardiac transplant outcomes after donor-derived HCV transmission.
Kobashigawa J, Khush K, Colvin M, Acker M, Van Bakel A, Eisen H, Naka Y, Patel J, Baran DA, Daun T, Luu M, Olymbios M, Rogers J, Jeevanandam V, Esmailian F, Pagani FD, Lima B, Stehlik J.
Cardiac transplantation remains the only definitive treatment for end-stage heart failure. Transplantation rates are limited by a shortage of donor hearts. This shortage is magnified because many hearts are discarded because of strict selection criteria and concern for regulatory reprimand for less-than-optimal posttransplant outcomes. There is no standardized approach to donor selection despite proposals to liberalize acceptance criteria. A donor heart selection conference was organized to facilitate discussion and generate ideas for future research. Participants debated misconceptions and established agreement on donor and recipient risk factors for donor selection and identified the components necessary for a future donor risk score. With agreement on the most important donor and recipient risk factors, it is anticipated that a consistent approach to donor selection will improve rates of heart transplantation.
Arsalan M, Squiers JJ, Herbert MA, MacHannaford JC, Chamogeorgakis T, Prince SL, Hamman BL, Knoff C, Moore DO, Harrington KB, DiMaio JM, Mack MJ, Brinkman WT.
Immediate surgery is standard therapy for acute type A aortic dissections (TAAD). Because of its low incidence, many smaller cardiac surgery programs do not routinely perform this procedure because it may negatively affect outcomes. Many high-risk, low-volume (LV) surgical procedures are now preferentially performed in reference centers. We compared the outcomes of surgery for TAAD in high-volume (HV) and LV centers in a single metropolitan area to determine the optimal setting for treatment.
Benjamin MM, Afzal A, Chamogeorgakis T, Feghali GA.
A 70-year-old man who presented with dyspnea and intermittent chest pain was found to have a large free-floating right atrial thrombus on two-dimensional echocardiogram. Atriotomy was performed, and an 18-cm-long thrombus was removed from the right atrium and inferior vena cava. Postoperatively, the patient developed cardiogenic shock treated by intravenous vasopressor agents and extracorporeal membrane oxygenation. The postoperative course was also complicated by bilateral pulmonary emboli requiring pulmonary artery thrombectomy. Right atrial thrombus is an underdiagnosed condition with a high mortality rate. The best management modality has not yet been established.
Jacob S, MacHannaford JC, Chamogeorgakis T, Gonzalez-Stawinski GV, Felius J, Rafael AE, Malyala RS, Lima B.
Venoarterial extracorporeal membrane oxygenation (ECMO) can provide temporary cardiopulmonary support for patients in hemodynamic extremis or refractory heart failure until more durable therapies-such as cardiac transplantation or a left ventricular assist device-can be safely implemented. Conventional ECMO cannulation strategies commonly employ the femoral artery and vein, constraining the patients to the supine position for the duration of ECMO support. We have recently adopted a modified cannulation approach to promote patient mobility, rehabilitation, and faster recovery and to mitigate complications associated with femoral arterial cannulation, such as limb ischemia and compartment syndrome. This technique involves cannulation of the subclavian artery and vein. The current case report details our recent experience with this approach in a critically ill patient awaiting cardiac transplantation.
O'Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G.
Early mortality in patients with ESRD is comparable to previously published data on extreme-risk patients without ESRD, but our data suggest a higher mortality rate at 1 year for ESRD patients, likely due to comorbid conditions. Stroke and major vascular injury are infrequent, and improved valve hemodynamics are maintained at 1 year.
Rich JD, Gosev I, Patel CB, Joseph S, Katz JN, Eckman PM, Lee S, Sundareswaran K, Kilic A, Bethea B, Soleimani B, Lima B, Uriel N, Kiernan M, Evolving Mechanical Support Research Group (EMERG) Investigators.
Early right-sided heart failure (RHF) after left ventricular assist device (LVAD) implantation is associated with increased mortality, but little is known about patients who develop late RHF (LRHF). We evaluated the incidence, risk factors, and clinical impact of LRHF in patients supported by axial-flow LVADs.
Roberts WC, Grayburn PA, Hamman BL.
Described herein is a 67-year-old morbidly obese man who had a lipoma excised from his posterior mitral leaflet after it was found by echocardiogram. Findings in 6 other previously reported cases are reviewed.
Squiers JJ, Lima B, DiMaio JM.
Squiers JJ, Saracino G, Chamogeorgakis T, MacHannaford JC, Rafael AE, Gonzalez-Stawinski GV, Hall SA, Lima B.
A standardized definition for primary graft dysfunction (PGD) after cardiac transplantation was recently proposed by the International Society of Heart and Lung Transplantation (ISHLT). We sought to characterize the outcomes associated with and identify risk factors for PGD following cardiac transplantation using these criteria at a high volume centre.
Shaikh AF, Joseph SM, Lima B, Hall SA, Malyala R, Rafael AE, Gonzalez-Stawinski GV, Chamogeorgakis T.
Left ventricular assist devices (LVADs) have revolutionized the treatment of patients with end-stage heart failure. These devices are replaced when pump complications arise if heart transplant is not possible. We present our experience with HeartMate II (HMII (Thoratec, Plesanton, California, United States)) LVAD pump exchange.
Jacob S, Patel MJ, Lima B, Felius J, Malyala RS, Chamogeorgakis T, MacHannaford JC, Gonzalez-Stawinski GV, Rafael AE.
Rupture of the ventricular septum during acute myocardial infarction usually occurs within the first week. The event is usually followed by low cardiac output, heart failure, and multiorgan failure. Despite the many advances in the nonoperative treatment of heart failure and cardiogenic shock, including the intra-aortic balloon pump and a multitude of new inotropic agents and vasodilators, these do not supplant the need for operative intervention in these critically ill patients. This article describes the successful use of extracorporeal membrane oxygenation support as a bridge to recovery postoperatively in a patient with a large infarct-produced ventricular septal defect.
Roberts WC, Won VS, Vasudevan A, Kapoor P, Ko JM, Meyer DM, Hall SA, Gonzalez-Stawinski GV.
Heart transplantation (HT) increases at some centers each year and decreases at others. We examined characteristics of patients having HT at the same hospital in 2 different time periods (1997-2012 and 2013-2015) by 2 different surgical groups. We compared certain clinical and morphological finding in 291 patients having HT 1997 to 2012 to finding in 228 other patients having HT from 2013 to 2015.
Chamogeorgakis T, Joseph S, Hall S, Gonzalez-Stawinski GV, Saracino G, Rafael A, MacHannaford J, Toumpoulis I, Mendez J, Lima B.
Although the impact of older donors on heart transplant outcomes has been previously published, the survival results are conflicting. We herein analyse the impact of older donors on transplant survival and myocardial function.
Patankar GR, Grayburn PA, Hebeler RF Jr, Henry AC, , Stoler RC.
Lima B, Chamogeorgakis T, MacHannaford JC, Rafael A, Gonzalez-Stawinski GV, Lima Md B.
Infiltrative processes that extend into the intervalvular fibrosa, such as infection or calcification, often mandate a complex reconstructive procedure known as the Commando operation. First described less than 20 years ago, this operation is not widely implemented, with experience limited to a few select centers. This report provides a detailed summary of our approach to this intricate procedure.
Gonzalo V. Gonzalez-Stawinski, MD
In this edition of The Journal of Cardiac Heart Failure, 2 papers aim to inform readers of donor groups that could be considered at the time of cardiac donation in the hope of expanding the stagnant donor pool.
Adams J, Lotshaw A, Exum E, Campbell M, Spranger CB, Beveridge J, Baker S, McCray S, Bilbrey T, Shock T, Lawrence A, Hamman BL, Schussler JM.
An alternative approach to prescribing sternal precautions after median sternotomy, “Keep Your Move in the Tube”. Proceedings Baylor University Medical Center 2016; 29(1): 97-100.
Carey S, Jackson WT, Hitchcock MA, Lima B, Hall S. Development of a Squamous Cell Carcinoma of the Hand and Wrist After Cardiac Transplantation. American Journal of Cardiology 2016; 117(11): 1853-1854.
Filardo G, Hamman BL, Pollock BD, da Graca B, Sass DM, Phan TK, Edgerton J, Prince SL, Ring WS. Excess short-term mortality in women after isolated coronary artery bypass graft surgery. Open Heart 2016; 3(1): e000386.
Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall S. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device. The American Journal of Cardiology 2016; 117(10): 1622-1628.
Lima B. Invited Commentary: Using “broken hearts” for cardiac transplantation: a risky venture or fruitful endeavor? Proceedings Baylor University Medical Center 2016; 29(1): 74. 75.
Loor G, Schuster A, Cruz V, Rafael A, Stewart WJ, Diaz J, McCurry K. The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability. Journal of Cardiothoracic Surgery 2016; Epub.
Roberts WC, Won VS, Vasudevan A, Ko JM, Hall SA, Gonzalez-Stawinski GV. Frequency of Massive Cardiac Adiposity (Floating Heart) in the Native Hearts of Patients Having Heart Transplantation at a Single Texas Hospital (2013 to 2015) and Comparison of Various Clinical and Morphologic Variables in the Patients With Massive Versus Nonmassive Cardiac Adiposity. The American Journal of Cardiology 2016; 117(8): 1375-1380.
Roberts WC, Won VS, Weissenborn MR, Khalid A, Lima B. Massive Diffuse Calcification of the Ascending Aorta and Minimal Focal Calcification of the Abdominal Aorta in Heterozygous Familial Hypercholesterolemia. American Journal of Cardiology 2016; 117(8): 1381-1385.
Roberts WC, Hall SA, Ko JM, McCullough PA, Lima B. Atrophy of the Heart After Insertion of a Left Ventricular Assist Device and Closure of the Aortic Valve. American Journal of Cardiology 2016; 117(5): 878-879.
Roberts WC, Moore M, Ko JM, Hamman BL. Mitral Valve Replacement After Failed Mitral Ring Insertion With or Without Leaflet/Chordal Repair for Pure Mitral Regurgitation. The American Journal of Cardiology 2016; 117(11): 1790-1807.
Squiers JJ, Lima B, DiMaio JM. Contemporary extracorporeal membrane oxygenation therapy in adults: Fundamental principles and systematic review of the evidence. The Journal of Thoracic and Cardiovascular Surgery 2016; Epub.
Whitson BA, Lima B. Surgery for acquired cardiac disease: An evolving paradigm with a promising future. The Journal of Thoracic and Cardiovascular Surgery 2016; 151(6): 1466-1469.
Ahmad FS, Kallen MA, Schifferdecker KE, Carluzzo KL, Yount SE, Gelow JM, Mccullough PA, Kimmel SE, Fisher ES, Cella D. Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure. Circulation Heart Failure June 2019; 12(6): e005751.
Ailawadi G, Lim DS, Mack MJ, Trento A, Kar S, Grayburn PA, Glower DD, Wang A, Foster E, Qasim A, Weissman NJ, Ellis J, Crosson L, Fan F, Kron IL, Pearson PJ, Feldman T, EVERST II Investigators. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation. Circulation Jan 2019; 139(1): 37-47.Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC: Heart Failure June 2019; 7(6): 457-465.
Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O’Neill WO, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovascular Interventions May 2019; Epub.
Barbin CM, Vasudevan A, Choi JW, McCullough PA, Schussler JM, Vallabhan RC, Stoler RC. Frequency of abnormal fractional flow reserve measurements among major coronary arteries. Cardiovascular Revascularization Medicine Feb 2019; 20(2): 143-146.
Blankenship JC, Choi JW, Das TS, McElgunn PM, Mukherjee D, Paxton LL, Piana R, Sauer JR, White CJ, Duffy PL. SCAI/ACVP expert consensus statement on cardiovascular catheterization laboratory economics: If the cath lab is your home, you should understand its finances: This statement was endorsed by the Alliance of Cardiovascular Professionals (ACVP) in April 2019. Catheterization and Cardiovascular Interventions 2019; In Press.
Brown K, Adams J, McCullough PA. Comparison of reflex, resistance training, and core activities using change in blood pressure over time after spontaneous coronary artery dissection. Baylor University Medical Center Proceedings Jan 2019; 32(1): 113-115.
Chalkley RA, Kim CW, Choi JW, Roberts WC, Schussler JM. Smeloff-Cuttler Mechanical Prosthesis in the Aortic Position for 40 Years. The American Journal of Cardiology May 2019; Epub.
Dawkins JD, Cedars AM, Schussler JM. Transulnar access for coronary intervention in a 23-year old with accelerated coronary atherosclerosis due to congenital aortic hypoplasia. Clinical Case Reports Jan 2019; 7(3): 435-437.
Dewan P, Rorth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Kober L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Differential Impact of Heart Failure with Reduced Ejection Fraction on Men and Women. Journal of the American College of Cardiology Jan 2019; 73(1): 29-40.
Dewan R, Rorth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Kober L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV, PARADIGM-HF and ATMOSPHERE Investigators. Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis. JACC Heart Failure April 2019; 7(4): 336-346.
Dewan R, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Kober L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr., Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV. Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. European Journal of Heart Failure May 2019; 21(5): 577-587.
Goyal A, Chatterjee K, Mathew RO, Sidhu MS, Bangalore S, McCullough PA, Rangaswami J. In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States. CardioRenal Medicine Jan 2019; 9(1): 51-60.
Grayburn PA, Sannino A, Packer M. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework that Reconciles the Results of the MITRA-FR and COAPT Trials. JACC: Cardiovascular Imaging Feb 2019; 12(2): 353-362.
Grayburn PA, Chandrashekhar Y. Imaging Challenges in Tricuspid Regurgitation and Right Ventricular Failure. JACC: Cardiovascular Imaging April 2019; 12(4): 768-770.
Grayburn PA. The Challenge of Assessing Residual Mitral Regurgitation During MitraClip Procedures: Is 3-Dimensional Vena Contracta Area the Answer? JACC: Cardiovascular Interventions March 2019; 12(6): 592-594.
Grayburn PA. Multimodality Imaging of Suspected Mechanical Prosthetic Valve Obstruction: Importance of the Patient and the Clinical Context. JACC Cardiovascular Imaging Feb 2019; Epub.
Haase VH, Chertow GM, Block GA, Pergola PE, deGoma EM, Khawaja Z, Sharma A, Maroni BJ, McCullough PA. Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents. Nephrology Dialysis Transplantation Jan 2019; 34(1): 90-99.
House AA, Wanner C, Sarnak MJ, Pina IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGE, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA, Conference Participants. Heart failure in chronic kidney disease : conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International June 2019; 95(6): 1304-1317.
McCullough PA. Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson’s Disease. Cardiology and Therapy Jan 2019; Epub.
McCullough PA, Mehta HS, Cork DP, Barker CM, Gunnarsson C, Mollenkopt S, Van Houten JV, Verta P. The healthcare burden of disease progression in medicare patients with functional mitral regurgitation. Journal of Medical Economics June 2019; Epub.
McCullough PA, Todoran TM, Brilakis ES, Ryan MP, Gunnarsson C. Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures. Catheter Cardiovascular Interventions Feb 2019; 93(2): E90-E97.
Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. B-Type Natriuretic Peptide During Treatment with Sacubitril/Valsartan: The PARADIGM-HF Trial. Journal of the American College of Cardiology March 2019; 73(11): 1264-1272.
Packer M. What have we learned from randomized controlled trials of catheter ablation for atrial fibrillation in patients with chronic heart failure? Circulation: Arrhythmia and Electrophysiology April 2019; 12(4): e007222.
Packer M. Major reduction in the risk of sudden cardiac death in patients with chronic heart failure with the use of drug and device combinations that favorably affect left ventricular structure. European Journal of Heart Failure 2019; In Press.
Packer M. Is any patient with chronic heart failure receiving the right dose of the right beta-blocker in primary care? American Journal of Medicine 2019; In Press.
Packer M, Grayburn PA. Neurohormonal and Transcatheter Repair Strategies for Proportionate and Disproportionate Functional Mitral Regurgitation in Heart Failure. JACC: Heart Failure June 2019; 7(6): 518-521.
Packer M. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients with Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator. Circulation Arrhythmia and Electrophysiology June 2019; 12(6): e007430.
Packer M. Critical Role of the Epicardium in Mediating Cardiac Inflammation and Fibrosis in Patients with Type 2 Diabetes. Diabetes, Obesity and Metabolism 2019; In Press.
Packer M. Disproportionate Functional Mitral Regurgitation: A New Therapeutic Target in Patients with Heart Failure and a Reduced Ejection Fraction. European Journal of Heart Failure 2019; In Press.
Packer M. Electrophysiological interventions in the treatment of chronic heart failure: a comparison of the strength of evidence supporting cardiac resynchronization for electrical conduction delay and catheter ablation for atrial fibrillation. European Heart Journal April 2019; 21(4): 398-401.
Packer M. When Cardiovascular Trials Collide. European Heart Journal February 2019; 40(6): 501-504.
Packer M, Grayburn PA. Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure. Circulation May 2019; Epub.
Packer M. Is Long-Standing Atrial Fibrillation a Biomarker of or Contributor to the Symptoms or Progression of Chronic Heart Failure? The American Journal of Medicine June 2019; Epub.
Packer M. Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey. European Heart Journal May 2019; Epub.
Packer M. Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation. European Heart Journal June 2019; 40(23): 1873-1879.
Packer M. The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal range. European Journal of Heart Failure Feb 2019; 21(2): 156-162.
Qamer SZ, Malik A, Bayoumi E, Lam PH, Singh S, Packer M, Kanonidis IE, Morgan CJ, Abdelmawqoud A, Allman RM, Fonarow GC, Ahmed A. Digoxin Use and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. The American Journal of Medicine May 2019; Epub.
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA, American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement from the American Heart Association. Circulation March 2019; Epub
Rangaswami J, Soman S, McCullough PA. Key Updates in Cardio-Nephrology from 2018: Springboard to a Bright Future. Cardiorenal Medicine April 2019; 9(4): 222-228.
Rangaswami J, McCullough PA. Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse Outcomes. JACC Heart Failure June 2019; 7(6): 533.
Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dala P, Kapoor R, Lerma EV, Lerman M, McCormick N, Bangalore S, McCullough PA, Dadhania DM. Cardiovascular Disease in the Kidney Transplant Recipient: Epidemiology, Diagnosis and Management Strategies. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association – European Renal Association May 2019; 34(5): 760-773.
Reardon MJ, Feldman TE, Meduri CU, Makkar RR, O’Hair D, Linke A, Kereiakes DJ, Waksman R, Babliaros V, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchetche D, Rovin JD, Lhermusier T, Carrie D, Hodson RW, Allocco DJ, Meredith IT. Two-Year Outcomes After Transcatheter Aortic Valve Replacement with Mechanical vs. Self-Expanding Valves: The REPRISW III Randomized Clinical Trial. JAMA Cardiology March 2019; 4(3): 223-229.
Rizk DV, Silva AL, Pergola PE, Toto R, Warnock DG, Chin MP, Goldsberry A, O’Grady M, Meyer CJ, McCullough PA. Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease. Cardiorenal Medicine June 2019; 1-10.
Roberts CS, Carry MM, Choi JW, Grayburn PA, Roberts WC. Papillary fibroelastoma in the left atrium. Baylor University Medical Proceedings April 2019; 32(2): 247-248.
Roberts WC. Hazards of Mitral Valve Replacement for Mitral Stenosis Caused by Massive Mitral Annular Calcium with or without Aortic Valve Replacement for Aortic Stenosis. American Journal of Cardiology Feb 2019; 123(4): 650-657.
Roberts WC, Grayburn PA, Lander SR, Meyer DM, Hall SA. Effect of Progressive Left Ventricular Dilation on Degree of Mitral Regurgitation Secondary to Mitral Valve Prolapse. American Journal of Cardiology Jun 2019; 123(11): 1887-1888.
Roberts WC. Proceedings of the Editorial Board Meeting of The American Journal of Cardiology on March 17, 2019, in New Orleans, Louisiana. American Journal of Cardiology July 2019; 124(1): 164-165.
Roberts WC, Haque S, Hall SA. Total 12-Lead QRS Voltage in Patients Having Orthotopic Heart Transplantation for Heart Failure Caused by Adriamycin-Induced Cardiomyopathy. Cardiology (Switzerland) Feb 2019; 141(3): 172-175.
Roberts WC. Facts and Ideas from Anywhere. Baylor University Medical Center Proceedings March 2019; 32(2): 314-321.
Roberts WC. From the Editor Pellagra, Osler, Roberts, Goldberger, the Atherosclerotic Diet, Niacin, the Beginning of the Atherosclerotic Epidemic, and the First Lipid-Altering Drug. The American Journal of Cardiology Feb 2019; 123(4): 697-700.
Rorth R, Jhund PS, Kristensen SL, Desai AS, Kober L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. European Journal of Heart Failure Jan 2019; 21(1): 40-49.
Sannino A, Potluri S, Pollock B, Filardo G, Gopal A, Stoler RC, Szerlip M, Chowdhury A, Mack MJ, Grayburn PA. Impact of Mitral Stenosis on Survival in Patients Undergoing Isolated Transcatheter Aortic Valve Implantation. American Journal of Cardiology April 2019; 123(8): 1314-1320.
Soraija P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, Bae R, Dahle G, Mumtaz M, Grayburn P, Kapadia S, Babaliaros V, Guerrero M, Satler L, Thourani V, Bedogni F, Rizik D, Denti P, Dumonteil N, Modine T, Sinhal A, Chuang ML, Pompa JJ, Blanke P, Leipsic J, Muller D. Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. Journal of the American College of Cardiology March 2019; 73(11): 1250-1260.
Spinowitz BS, Fishbane S, Pergola PE, Roger SD, Lerma SD, Butler J, von Haehling S, Adler SH, Zhao J, Singh B, Lavin PT, McCullough PA, Kosiborod M, Packman DK, ZS-005 Study Investigators. Sodium Zirconium Cyclosillcate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study. Clinical Journal of American Society of Nephrology June 2019; 14(6): 798-809.
Sudhakaran S, McCullough PA. Common laboratory parameters as indicators of multi-organ dysfunction in acute heart failure. European Journal of Heart Failure June 2019; 21(6): 751-753.
Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights from an International Chronic Total Occlusion Registry. JACC Cardiovascular Interventions Feb 2019; 12(4): 346-358.
Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahumd E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients with Prior Coronary Artery Bypass Graft Surgery. Circulation. Cardiovascular Interventions March 2019; 12(3): e007338.
Tecson KM, Hashemi H, Afzal A, Gong TA, Kale P, McCullough PA. Community-Acquired Acute Kidney Injury as a Risk Factor of de novo Heart Failure Hospitalization. CardioRenal Medicine May 2019; 9(4): 252-260.
Vardeny O, Claggett B, Kachadourian J, Desai AS, Packer M, Rouleau J, Zile MR, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial. European Journal of Heart Failure March 2019; 21(3): 337-341.
Vasudevan A, Choi JW, Feghali GA, Lander SR, Jialiang L, Schussler JM, Stoler RC, Vallabhan RC, Velasco CE, McCullough PA. Event dependence in the analysis of cardiovascular readmissions postpercutaneous coronary intervention. Journal of Investigational Medicine Jan 2019; 0: 1-7.
Vijayaraghaven K, McCullough PA, Singh B, Gupta M, Enas E, Mohan V, Misra A, Deedwania P, Brinton EA. Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America. CardioRenal Medicine 2019; 9: 240-251.
Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samdy H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Drilakis ES. Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry). American Journal of Cardiology May 2019; 123(9): 1422-1428.
Xenogiannis I, Karmpaliotis D, Alaswad K, Basir MB, Yeh RW, Tamez H, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Khatri JJ, Sheikh AM, Malik BA, Greene ME, Abi Rafeh N, Maalou A, Abou Jaoudeh F, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Russo J, Hakemi E, Tajti P, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series. The Journal of Invasive Cardiology July 2019; 31(7): E220-E225.
Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P. Aterial Stiffness in the Heart Disease of CKD. Journal of the American Society of Nephrology: JASN Jun 2019; 30(6): 918-928.
Zile MR, O’Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefowitz M, Rouleau J. Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients with HfrEF. Journal of the American College of Cardiology Feb 2019; 73(7): 795-806.
Zoghbi WA, Asch FM, Bruce C, Gillam LD, Grayburn PA, Hahn RT, Inglessis I, Islam AM, Lerakis S, Little SH, Siegel RJ, Skubas N, Slesnick TC, Stewart WJ, Thavendiranathan P, Weissman NJ, Yasukochi S, Zimmerman KG. Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography and Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography April 2019; 32(4): 431-475.
Afzal A, Vallabhan RC, McCullough PA. Acute kidney injury in cardiogenic shock: in search of early detection and clinical certainty. European Journal of Heart Failure March 2018; 20(3): 582-584.
Al-Douri A, Cedars A, Tran D. Coronary artery fistula between the left anterior descending artery and pulmonary artery. Baylor University Medical Center Proceedings 2018; 31(1): 64-66.
Barbin CM, Vasudevan A, Choi JW, McCullough PA, Schussler JM, Vallabhan RC, Stoler RC. Frequency of abnormal fractional flow reserve measurements among major coronary arteries. Cardiovascular Revascularization Medicine April 2018; Epub.
Bilchick KC, Chishinga N, Parker AM, Zhuo DX, Rosner MH, Smith LA, Mwansa H, Blackwell JN, McCullough PA, Mazimba S. Plasma Volume and Renal Function Predict Six-Month Survival after Hospitalization for Acute Decompensation Heart Failure. CardioRenal Medical 2018; 8: 61-70.
Carey SA, Tecson KM, Bass K, Felius J, Hall SA. Patient activation with respect to advanced heart failure therapy in patients over age 65 years. Heart and Lung July 2018; 47(4): 285-289.
Chandra A, Lewis EF, Claggett BL, Desai AS, Packer M, Zile MR, Swedberg K, Rouleau JL, Shi VC, Lefkowitz MP, Katova T, McMurray JJV, Solomon SD. Effects of sacubitril/valsartan on physical and social activity limitations in patients with heart failure, A secondary analysis of the PARADIGM-HF trial. JAMA Cardiology June 2018; 3(6): 498-505.
Cherney DZI, Lytvyn Y, McCullough PA. Cardiovascular Risk Reduction in Patients with Chronic Kidney Disease: Potential for Targeting Inflammation with Canakinumab. Journal of the American College of Cardiology May 2018; 71(21): 2415-2418.
Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, Manzano L, McMurray JJV, Ruschitzka F, van Veldhuisen DJ, von Lueder TG, Böhm M, Andersson B, Kjekshus J, Packer M, Rigby AS, Rosano G, Wedel H, Hjalmarson Å, Wikstrand J, Kotecha D; Beta-blockers in Heart Failure Collaborative Group. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. European Heart Journal Jan 2018; 39(1): 26-35.
Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC: Heart Failure June 2018; 6(6): 489-498.
Danek BA, Basir MB, O’Neill WW, Alqarqaz M, Karatasakis A, Karmpaliotis D, Jaffer FA, Yeh RW, Wyman M, Lombardi WL, Kandzari D, Lembo N, Doing A, Patel M, Mahumd E, Choi JW, Toma C, Moses JW, Kirtane A, Parikh M, Ali ZA, Garcia S, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES, Alaswad K. Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from a Multicenter U.S. Registry. Journal of Invasive Cardiology March 2018; 30(3): 81-87.
De Albuquerque Rocha N, Neeland IJ, McCullough PA, Toto RD, McGuire DK. Effects of sodium glucose co-transporter 2 inhibitors on the kidney. Diabetes and Vascular Disease Research June 2018; In Press.
Ewing MJ, Eidt JF. CON: Contrast-induced nephropathy-should we try to avoid contrast media in patients with chronic kidney disease? Nephrology Dialysis Transplantation June 2018; Epub.
Farzad A, Schussler JM. Acute Myopericardial Syndromes. Cardiology Clinics Feb 2018; 36(1): 103-114.
Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchetche D, Rovin JD, Buchbinder M, Meredith IT, Gotberg M, Bjursten H, Meduri C, Salinger MH, Allocco DJ, Dawkins KD. Effect of Mechanically Expanded vs. Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients with Aortic Stenosis: The REPRISW III Randomized Clinical Trial. JAMA Jan 2018; 319(1): 27-37.
Gong TA, Hall SA. Targeting Other Modifiable Risk Factors for the Prevention of Heart Failure: Diabetes, Smoking, Obesity, and Inactivity. Current Cardiovascular Risk Reports 2018; 12: 12.
Grayburn PA. Evaluating Patients with Low-Flow, Low-Gradient Aortic Stenosis by Dobutamine Echocardiography: It’s Complicated. Journal of the American College of Cardiology Feb 2018; 71(5): 486-488.
Haase VH, Chertow GM, Block GA, Pergola PE, deGoma EM, Khawaja Z, Sharma A, Maroni BJ, McCullough PA. Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents. Nephrology Dialysis Transplantation 2018; 1-10.
Hashemi H, Raza FS, Harmon DM, Alias T, Felius J, Sherwood MJ. Usefulness of left ventricular assist device in patients with left ventricular noncompaction. Baylor University Medical Center Proceedings 2018; 31(1): 61-63.
Howard CE, Garett JS, Stoler RC, Schussler JM. Overall survival and brain death frequency following out-of-hospital cardiac arrest. Proceedings Baylor University Medical Center Jan 2018; 31(1): 6-8.
Jenkins N, Adams J, Bilbrey T, McCray S, Schussler JM. Specificity of training in cardiac rehabilitation to facilitate a patient’s return to stenuous work following aortic valve replacement. Proceedings Baylor University Medical Center Feb 2018; 31(1): 72-75.
Kale P, Afzal A. Stage B Heart Failure: To Strain or Not to Strain. JACC: Cardiovascular Imaging 2018; In Press.
Kandzari DE, Bohm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, Cohen SA, Fahy M, Pilcher G, Kario K, Aoki J, Batson B, Cohen DL, Dangas G, David S, Davies J, Devireddy CM, Kario K, Lee DP, Papademtriou V, Patel M, Patel K, Schmieder RE. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomized trial. The Lancet June 2018; 391(10137): 2346-2355.
Keuffel E, McCullough PA, Todoran TM, Brilakis ES, Palli SR, Ryan MP, Gunnarsson C. The effect of major adverse cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty. Journal of Medical Economics April 2018; 21(4): 356-364.
Mack M, Vasudevan A, Hamandi M. TAVR in younger patients with aortic stenosis: anything new? EuroIntervention May 2018; 14: 29-30.
Maioli M, Toso A, Leoncini M, Musilli N, Grippo G, Ronco C, McCullough PA, Bellandi F. Bioimpedance-Guided Hydration for Prevention of Contrast-Induced Kidney Injury: The HYDRA Study. Journal of the American College of Cardiology June 2018; 71(25): 2880-2889.
Maisel AS, Daniels LB, Anand IS, McCullough PA, Chow SL. Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy. Postgraduate Medicine April 2018; 130(3): 299-307.
McCullough PA, Kluger AY. Interpreting the Wide Range of NT-proBNP Concentrations in Clinical Decision Making. Journal of the American College of Cardiology Mar 2018; 71(11): 1201-1203.
McCullough PA. Editorial: Robertsonian Perspectives on Atherosclerosis: The Power of Direct Observation. American Journal of Cardiology June 2018; 121(11): 1441.
McCullough PA, Ballantyne CM, Sanganalmath SK, Langslet G, Baum SJ, Shah PK, Koren A, Mandel J, Davidson MH. Efficacy and Safety of Alirocumab in High-Risk Patients with Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials. The American Journal of Cardiology April 2018; 121(8): 940-948.
McCullough PA, Daeid G, Todoran TM, Brilakis ES, Ryan MP, Gunnarsson C. Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention. Journal of Comparative Effectiveness Research April 2018; 7(4): 331-341.
McCullough PA, Rangaswami J. Real or Perceived: Hyperkalemia is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart Failure. Nephron 2018; 138(3): 173-175.
McCullough PA, Uhlig K, Neylan JF, Pergola PE, Fishbane S. Usefulness of Oral Ferric Citrate in Patients with Iron-Deficiency Anemia and Chronic Kidney Disease with or without Heart Failure. American Journal of Cardiology 2018; In Press.
Mills B, Dishner E, Velasco CE. Acute myocardial infarction triggered by use of synthetic cannabis. Proceedings Baylor University Medical Center March 2018 12;31(2).
Mogensen UM, Gong J, Jhund PS, Shen L, Køber L, Desai AS, Lefkowitz MP, Packer M, Rouleau JL, Solomon SD, Claggett BL, Swedberg K, Zile MR, Mueller-Velten G, McMurray JJV. Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). European Journal of Heart Failure April 2018; 20(4): 760-768.
Ostermann M, McCullough PA, Forni LG, Bagshaw SM, Joannidis M, Shi J, Kashani K, Honore PM, Chawla LS, Kellum JA, all SAPHIRE Investigators. Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults. Critical Care Medicine March 2018; 46(3): 375-383.
Packer M. Response by Dr. Packer to the Letter of Dr. Blankfield. Journal of Cardiovascular Pharmacology and Therapeutics Jan 2018; 23(1): 99-100.
Packer M. The future treatment of heart failure? European Heart Journal Jan 2018; 39(1): 5-16.
Packer M. Data Sharing in Medical Research: Trust is the elephant in the room. BMJ Feb 2018; 360: k510.
Packer M. Derangements in adrenergic-adipokine signaling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction. European Journal of Heart Failure May 2018; 20(5): 873-878
Packer M. Do Most Obese People with Exercise Intolerance and a Normal Ejection Fraction Have Treatable Heart Failure? The American Journal of Medicine March 2018; Epub.
Packer M. Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Infulence of Concomitant Antidiabetic Medications. JACC Heart Failure June 2018; 6(6): 445-451.
Packer M, Kitzman DW. Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2. JACC Heart Failure March 2018; Epub.
Packer M. Do DPP-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically-Mediated Cardiotoxicity? Clues from Laboratory Models and Clinical Trials. Circulation Research March 2018; 122(7): 928-932.
Packer M. Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial. European Journal of Heart Failure Jan 2018; 20(1): 49-51.
Packer M. Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis. Diabetes, Obesity and Metabolism June 2018; 20(6): 1361-1366.
Packer M. Have we really demonstrated the cardiovascular safety of anti-hyperglycemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetes. Diabetes, Obesity and Metabolism May 2018; 20(5): 1089-1095.
Packer M. Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines. Cardiovascular Diabetology Jan 2018; 17(1): 9.
Packer M. Should We Be Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Treating Diabetes? The American Journal of Medicine May 2018; 131(5): 461-463.
Packer M. Is the Popularity of Dipeptidyl-Peptidase-4 Inhibitors Justified? Insights From Mechanistic Studies and Clinical Trials. The American Journal of Medicine July 2018; 131(7): e287-e289.
Packer M. Does Neprilysin Inhibition Potentiate or Minimize the Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Heart Failure? Journal of Cardiac Failure Feb 2018; 24(2): 109-111.
Packer M. Acute Heart Failure Is an Event Rather Than a Disease: Plea for a Radical Change in Thinking and in Therapeutic Drug Development. JACC Heart Failure Jan 2018; 6(1): 73-75.
Packer M. Is metformin beneficial for heart failure in patients with type 2 diabetes? Diabetes Research and Clinical Practice Feb 2018; 136: 168-170.
Packer M. Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes. Diabetes Care Jan 2018; 41(1): 11-13.
Packer M, Claggett B, Lefkowitz MP, McMurray JJV, Rouleau JL, Solomon SD, Zile MR. Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial. The Lancet Diabetes and Endocrinology July 2018; 6(7): 547-554.
Packer M. Contrasting effects on the risk of macrovascular and microvascular events of antihyperglycemic drugs that enhance sodium exretion and lower blood pressure. Diabetic Medicine June 2018; 35(6): 707-713.
Packer M. Potential mechanisms underlying differences in the effect of incretin-based antidiabetic drugs on the risk of major atherosclerotic ischemic events. Journal of Diabetes and its Complications June 2018; 32(6): 616-617.
Packer M. Augmentation of glucagon-like peptide-1 receptor signaling by neprilysin inhibition: Potential implications for patients with heart failure. European Journal of Heart Failure 2018; In Press.
Packer M. Higher Mortality Rate in Patients with Heart Failure Who Are Taking Commonly Prescribed Antidiabetic Medications and Achieve Recommended Levels of Glycaemia Control. Diabetes, Obesity and Metabolism July 2018; 20(7): 1766-1769.
Packer M. Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medications. European Journal of Heart Failure March 2018; Epub.
Packer M. Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparators. International Journal of Cardiology June 2018; 261(15): 130-133.
Packer M. Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes. Diabetes, Obesity and Metabolism April 2018; 20(4): 800-811.
Packer M. Potentiation of Insulin Signaling Contributes to Heart Failure in Type 2 Diabetes: A Hypothesis Supported by Both Mechanistic Studies and Clinical Trials. JACC: Basic to Translational Science June 2018; 3(3); 415-419.
Rangaswami J, Mathew RO, McCullough PA. Resuscitation for the specialty of nephrology: is cardionephrology the answer? Kidney International Jan 2018; 93(1): 25-26.
Rangaswami J, Naranjo M, McCullough PA. Preeclampsia as a Form of Type 5 Cardiorenal Syndrome: An Underrecognized Entity in Women’s Cardiovascular Health. CardioRenal Medicine Apr 2018; 8L 160-172.
Rangaswami J, McCullough PA. Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients with Worsening Heart Failure: The Devil is in the Details. JACC: Heart Failure Mar 2018; 6(3): 266-267.
Reddy VY, Koruth J, Jais P, Petru J, Timko F, Skalsky I, Hebeler R, Labrousse L, Barandon L, Kralovec S, Funosako M, Mannuva BB, Sediva L, Neuzil P. Ablation of Atrial Fibrillation with Pulsed Electric Fields: An Ultra-Rapid, Tissue-Selective Modality for Cardiac Ablation. JACC: Clinical Electrophysiology 2018; In Press.
Rengarajan R, McCullough PA, Chowdhury A, Tecson KM. Identifying suspected familial chylomicronemia syndrome. Baylor University Medical Center Proceedings 2018; 31(3): 284-288.
Roberts WC, Schussler JM. Frequency of Plaque Dislodgement and Embolization in Transradial vs Transfermoral Approaches for Left-Sided Cardiac Catheterization Clinically Silent vs Clinically Apparent Embolism. JAMA Cardiology May 2018
Roberts WC, Grayburn PA, Hall SA. Complications of Radiofrequency Ablation for Supraventricular Tachycardia in the Wolff-Parkinson-White Syndrome Associated with Noncompaction Cardiomyopathy. American Journal of Cardiology June 2018; 121(11): 1442-1444.
Roberts WC. Cardiac rupture during acute myocardial infarction diagnosed clinically. Coronary Artery Disease 2018; 29(2): 95-96.
Roberts WC. Quantitative Extent of Atherosclerotic Plaque in the Major Epicardial Coronary Arteries in Patients with Fatal Coronary Disease, in Coronary Endarterectomy Specimens, in Aorta-Coronary Saphenous Venous Conduits, and Means to Prevent the Plaques: A Review after Studying the Coronary Arteries for 50 Years. American Journal of Cardiology June 2018; 121(11): 1413-1435.
Roberts WC. Good Books Received in Cardiovascular Disease in 2017 and in Early 2018. The American Journal of Cardiology April 2018; Epub.
Roberts WC. Facts and ideas from anywhere. Baylor University Medical Center Proceedings June 2018; 31(3): 389-400.
Roberts WC, Kondapalli N, Guileyardo JM. Morphologic Findings in Donor (Transplanted) Hearts at Necropsy Early and Late After Orthotopic Heart Transplantation. The American Journal of Cardiology Jan 2018; 121(2): 217-240.
Roberts WC, Becker TM, Hall SA. Usefulness of Total 12-Lead QRS Voltage as a Clue to Diagnosis of Patients with Cardiac Sarcoidosis Severe Enough to Warrant Orthotopic Heart Transplant. JAMA Cardiology Jan 2018; 3(1): 64-68.
Rocha NA, McCullough PA. Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials. Kidney International Supplements Jan 2018; 8(1): 8-17.
Sannino A, Grayburn PA. Mitral Regurgitation in Patients with Severe Aortic Stenosis: Diagnosis and Management. Heart (British Cardiac Society) Jan 2018; 104(1): 16-22.
Sannino A, Szerlip M, Harrington K, Schiattarella GG, Grayburn PA. Comparison of Baseline Characteristics and Outcomes in Men Versus Women with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. American Journal of Cardiology April 2018; 121(7): 844-849.
Tajti P, Karmpaliotis D, Alaswad K, Toma C, Choi JW, Jaffer FA, Doing AH, Patel M, Mahmud E, Uretsky B, Karatasakis A, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Prevalence, Presentation and Treatment of ‘Balloon Undilatable’ Chronic Total Occlusions: Insights from a Multicenter US Registry. Catheterization and Cardiovascular Interventions March 2018; 91(4): 657-666.
Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES. The Hybrid Approach to Chonic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry. JACC: Cardiovascular Interventions April 2018; Epub.
Tajti P, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Toma C, Uretsky B, Garza S, Moses JW, Parikh M, Kirtane A, Ali ZA, Hatem R, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights from a Multicenter U.S. Registry. Journal of Invasive Cardiology March 2018; 30(3): 89-96.
Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Toma C, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure. American Journal of Cardiology 2018; In Press.
Tecson KM, Vasudevan A, Bindra A, Joseph SM, Felius J, Hall SA, Kale P. Validation of Peripherally Inserted Central Catheter-Derived Fick Cardiac Outputs in Patients with Heart Failure. American Journal of Cardiology Jan 2018; 121(1): 50-54.
Vaduganathan M, Claggett B, Packer M, McMurray JJV, Rouleau JL, Zile MR, Swedberg K, Solomon SD. Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure. JACC Heart Failure March 2018; Epub.
Van Meter C, Vasudevan A, Cuccerre JM, Schussler JM. Time to discharge following diagnostic coronary procedures via transradial artery approach: A comparison of Terumo band and StatSeal hemostasis. Cardiovascular Revascularization Medicine Mar 2018; Epub.
Vasudevan A, Hundae Aneley, Borodge D, McCullough PA, Wells PJ. Frequency of atrial arrhythmias after atrial flutter ablation and the effect of presenting rhythm on the day of ablation. Proceedings Baylor University Medical Center May 2018;
Vemulapalli S, Holmes DR Jr., Dai D, Matsouaka R, Mack MJ, Grover FL, Makkar RR, Thourani VH, Douglas PS. Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry. American Heart Journal Jan 2018; 195: 1-13.
Vetrovec GW, Anderson M, Schreiber T, Popma J, Lombardi W, Maini B, Moller JE, Schafer A, Dixon SR, Hall S, Ohman EM, Mindrescu C, Moses J, O’Neill W. The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure. American Heart Journal May 2018; 199: 115-121.
Virzi GM, Zhang J, Nalesso F, Ronco C, McCullough PA. The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome. CardioRenal Medicine Jan 2018; 8: 92-104.
Zhang J, Tecson KM, Rocha NA, McCullough PA. Usefulness of alircumab and evolocumab for the treatment of patients with diabetic dyslipidemia. Proceedings Baylor University Medical Center April 2018; 31(2): 180-184.
Adesina GO, Hall SA, Mendez JC, Joseph SM, Gottlieb RL, Kale PP, Bindra AS. Arrthmogenic Right Ventricular Dysplasia: An Under-recognized Form of Inherited Cardiomyopathy . Reviews in Cardiovascular Medicine 2017; 18(1): 37-43.
Afzal A, Sarmast S, Choi JW, McCullough PA, Schussler JM. Spontaneous Coronary Artery Dissection: A Review of Pathogenesis, Presentations, Treatment, and Outcomes. Reviews in Cardiovascular Medicine 2017; 18(1): 29-36.
Ailawadi G, Chang HL, O’Gara PT, O’Sullivan K, Woo YJ, DeRose JJ, Parides MK, Thourani VH, Robichaud S, Gillnov AM, Taddei-Peters WC, Miller MA, Perrault LP, Smith RL, Goldsmith L, Horvath KA, Doud K, Baio K, Gelijns AC, Moskowitz AJ, Begiella E, Alexander JH, Iribarne A. Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network. The Journal of Thoracic and Cardiovascular Surgery Jun 2017; 153(6): 1384-1391.
Arsalan M, Squiers JJ , Filardo G, Pollock B, DiMaio JM , Prava B, Gopal A, Mahoney AC, Brown DL, Mack MJ, Grayburn PA. Effect of Elliptical LV Outflow Tract Geometry on Classification of Aortic Stenosis in a Multidisciplinary Heart Team Setting. JACC: Cardiovascular Imaging . Jan 2017; In press.
Arsalan M, Walther T, Smith RL, Grayburn PA. Tricuspid regurgitation diagnosis and treatment. European Heart Journal March 2017; 38(9): 634-638.
Becker TM, Grayburn PA, Roberts WC. Mitral Valve Repair for Pure Mitral Regurgitation Followed Years Later by Mitral Valve Replacement for Mitral Stenosis. American Journal of Cardiology Jul 2017; 120(1): 160-166.
Benjamin MM, Afzal A, Chamogeorgakis T, Feghali GA. Right atrial thrombus and its causes, complications, and therapy. Proceedings Baylor University Medical Center Jan 2017; 30(1): 54-56.
Blackbourne BD, Vasudevan A, Roberts WC. Comparison at Necropsy of Heart Weight in Women Aged 20 to 29 Years With Fatal Trauma of Chemical Intoxication Versus Fatal Natural Cause (A Search for the Normal Adult Heart Weight ). American Journal of Cardiology Mar 2017; 119(5): 808-812.
Blanke P, Park JK, Grayburn P , Naoum C, Ong K, Kohli K, Norgaard BL, Webb JG, Popma J, Boshell D, Sorajja P, Muller D, Leipsic J. Left ventricular access point determination for a coaxial approach to the mitral annular landing zone in transcatheter mitral valve replacement. Journal of Cardiovascular Computed Tomography Apr 2017; Epub.
Bohm M, Young R, Jhund PS, Solomon SD, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Packer M, McMurray JJV. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF. European Heart Journal Apr 2017; 38(15): 1132-1143.
Cannon JA, Shen L, Jhund PS, Kristensen SL, Kober L, Chen F, Gong J, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJV, on behalf of the PARADIGM-HF Investigators and Committees. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. European Journal of Heart Failure Jan 2017; 19(1): 129-137.
Carey SA, Bass K, Saracino G, East CA, Felius J, Grayburn PA, Vallabhan RC, Hall SA. Probability of Accurate Heart Failure Diagnosis and the Implications for Hospital Readmissions. The American Journal of Cardiology Apr 2017; 119(7): 1041-1046.
Castro MDM, Cossio A, Velasco C, Osorio L. Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study. PLo S Negl Trop Dis. 2017 Apr 5;11(4). eCollection 2017 Apr.
Chen S, Grayburn PA. Ultrasound-targeted microbubble destruction for cardiac gene delivery . Methods in Molecular Biology Jan 2017; 1521: 205-218.
Dehmer GJ, Holper EM. Does Practice Make Perfect? JACC Cardiovascular Interventions May 2017; 10(9): 928-930.
Desai AS, Vardeny O, Claggett B, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Zile MR, Lefowitz M, Shi V, Solomon SD. Reduced Risk of Hyperkalemia During Treatment of Heart Failure with Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared with Enalapril: A Secondary Analysis of the PARADIGM-HF Trial . JAMA Cardiology Jan 2017; 2(1): 79-85.
East C, Phan T, Filardo G, Franklin J, Donsky A, Wheelan KR, Kowal RC. Repeat ablation and hospitalization following cryoballoon ablation of atrial fibrillation at a single tertiary medical center. Proceedings Baylor University Medical Center Jan 2017; 30(1): 3-6.
El Chami M, Kowal RC, Soejima K, Ritter P, Duray GZ, Neuzil P, Mont L, Kypta A, Sagi V, Hudnall JH, Stromberg K, Reynolds D . Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter pacing study. Pacing Clinical Electrophysiology Apr 2017; Epub.
Elbehary S, Szerlip HM, McCullough PA. Potassium Excretion and Outcomes in CKD: is K Intake OK? American Journal of Kidney Diseases Mar 2017; 69(3): 325-327.
Farber AJ, Suarez K, Slicker K, Patel CD, Pope B, Kowal R, Michel JB. Frequency of Troponin Testing in Inpatient Versus Outpatient Settings . The American Journal of Cardiology Apr 2017; 119(8): 1153-1155.
Fendler TJ, Nassif ME, Kennedy KF, Joseph SM, Silvestry SC, Ewald GA, LaRue SJ, Vader JM, Spertus JA, Arnold SV. Global Outcome in Patients With Left Ventricular Assist Devices. The American Journal of Cardiology Apr 2017; 119(7): 1069-1073.
Habib PJ, Joseph SM. Why All the Pushback against Counterpulsation? Cardiology Jun 2017; 138(1): 66-68.
Hall, S. In Heart Failure, Where You Have Been May Be More Important Than Where You Are: A Role for Patient-Reported Outcomes. American Journal of Cardiology Mar 2017; 119(5): 813-815.
Harrison JK, Hughes GC, Reardon MJ, Stoler RC, Grayburn PA, Hebeler R, Liu D, Chang Y, Popma JJ, CoreValve US Clinical Investigators. Balloon Post-Dilation Following Implantation on a Self-Expanding Transcatheter Aortic Valve Bioprosthesis. JACC: Cardiovascular Interventions Jan 2017; 10(2): 168-175.
Howard C, Velasco CE , Roullard CP, Rafael A. Aorto-Right Atrial Fistula After Bentall Repair. Proceedings Baylor University Medical Center 2017; 30(3):301-302.
Howard CE, McCullough PA. Decoding Acute Myocardial Infarction among patients on dialysis. Journal of the American Society of Nephrology May 2017; 28(5): 1337-1339.
Jazi HH, McCullough PA. Fitness and strength in young adulthood and protection from future heart failure. Journal of Public Health and Emergency Mar 2017.
Joseph SM, Rich MW. Targeting Frailty in Heart Failure . Current Treatment Options in Cardiovascular Medicine Apr 2017; 19(4): 1-10.
Joseph SM. LVADs and Contemplations on a Flood . Journal of Cardiac Failure Feb 2017; 23(2): 95.
Karatasakis A, Iwnetu R, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Kandzari DE, Lembo NJ, Patel M, Mahmud E, Lombardi WL, Wyman RM, Grantham JA, Doing AH, Toma C, Choi JW, Uretsky BF, Moses JW, Kirtane AJ, Ali ZA, Parikh M, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. Journal of Invasive Cardiology Apr 2017; 29(4): 116-122.
Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Bohm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson A, Kjekshua J, Cleland JGF, Beta-Blockers in Heart Failure Collaborative Group. Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. Journal of the American College of Cardiology Jun 2017; 69(24): 2885-2896.
McCullough PA, Vasudevan A, Sathyamoorthy M, Schussler JM, Velasco CE, Lopez LR, Swift C, Peterson M, Bennett-Firmin J, Schiffmann R, Bottiglieri T. Urinary 11-Dehydro-Thromboxane B2 and Mortality in Patients with Stable Coronary Artery Disease. The American Journal of Cardiology Apr 2017; 119(7): 972-977.
McCullough PA, Zhang J, Ronco C. Volume expansion and contrast-induced acute kidney injury. The Lancet Apr 2017; 389(10076): 1277-1278.
McCullough PA. How Trialists and Pharmaceutical Sponsors Have Failed Us by Thinking That Acute Heart Failure Is a 48-Hour Illness. American Journal of Cardiology Jun 2017; In press.
McCullough PA. Reply: Vitamin E May Protect Against Contrast-Induced Acute Kidney Injury. Journal of the American College of Cardiology Apr 2017; 69(14): 1878-1879.
McCullough PA, Rios A, Smith B. Dialysis fistulas and heart failure. European Heart Journal Mar 2017; Epub.
Mogensen UM, Kober L, Kristensen SL, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJV. The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF . American Heart Journal Jun 2017; 188(1): 35-41.
Muller DWM, Farivar RS, Jansz P, Bae R, Walters R, Clarke A, Grayburn PA, Stoler RC, Dahle G, Rein KA, Shaw M, Scalia GM, Guerrero M, Pearson P, Kapadia S, Gillinov M, Pichard A, Corso P, Popma J, Chuang M, Blanke P, Leipsic J, Sorajja P. Transcatheter Mitral Valve Replacement for Patients with Symptomatic Mitral Regurgitation . Journal of the American College of Cardiology Jan 2017; 69(4): 381-391.
Nguyen HL, Yarzebski J, Lessard D, Gore JM, McManus DD, Goldberg RJ. Ten-year (2001-2011) trends in the incidence rates and short-term outcomes of early versus late onset cardiogenic shock after hospitalization for acute myocardial infarction. Journal of the American Heart Association Jun 2017; 6(6): e005566.
O’Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G . One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. The Annals of Thoracic Surgery May 2017; 103(5): 1392-1398.
Packer M, Armstrong WM, Rothstein JM, Emmett M. Sacubitril-Valsartan in Heart Failure. Annals of Internal Medicine May 2017; 166(9): 681-682.
Packer M, Holcomb R, Abraham WT, Anker S, Dickstein K, Filippatos G, Krum H, Maggioni AP, McMurray JJV, Mebazaa A, O’Conner C, Peacock F, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Holzmeister J, TRUE-AHF Investigators and Committtees. Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. European Journal of Heart Failure May 2017; 19(5): 673-681.
Packer M, McMurray JJV, Krum H, Kiowski W, Massie BM, Caspi A, Pratt CM, Petrie MC, DeMets D, Kobrin I, Roux S, Swedberg K, ENABLE Investigators and Committees. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients with Severe Chronic Heart Failure: Primary Results of the ENABLE Trials . JACC Heart Failure May 2017; 5(5): 317-326.
Packer M, McMurray JJV. Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensis system for the treatment of heart failure. Lancet May 2017; 389(10081): 1831-1840.
Packer M, O’Connor C, McMurray JJ, Wittes J, Abraham WT, Anker SD, Dickstein K, Fillppatos G, Holcomb R, Krum H, Maggioni AP, Mebazzaa A, Peacock WF, Petrie MC, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Kowarski LS, Schactman M, Holzmeister J, TRUE-AHF Investigators. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure . New England Journal of Medicine May 2017; 376(20): 1956-1964.
Packer M, Pitt B, Rouleau JL, Swedberg K, DeMets DL, Fisher L. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients with Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years . JACC: Heart Failure Jun 2017; 5(6): 399-407.
Packer M. Double Vision: Replicating a Trial Showing a Survival Benefit . JACC Heart Failure Mar 2017; 5(3): 232-235.
Packer M. Response by Dr. Packer to the Letter of Dr. Blankfield . Journal of Cardiovascular Pharmacology and Therapeutics Jan 2017; Epub.
Packer M. Response by Packer to Letter Regarding Article, “Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective”. Circulation Apr 2017; 135(15): e892-e893.
Packer M. Should recommendations for clinical use be restricted to patients who were enrolled in a pivotal clinical trial? European Journal of Heart Failure Jun 2017; 19(6): 779-781.
Packer M. Tetralogy of Fallow: Four Trials and Tribulations . JACC: Heart Failure Jun 2017; 5(6): 408-410.
Packer M. Let Us Not Forget the Long-term Safety Concerns of Sacubitril/Valsartan-Reply. JAMA Cardiology Mar 2017; Epub.
Piccini JP, Stromberg K, Jackson KP, Laager V, Durray GZ, El-Chami M, Ellis CR, Hummel J, Jones DR, Kowal RC, Narasimhan C, Omar R, Ritter P, Roberts PR, Soejima K, Zhang S, Reynolds D, Micra Transcatheter Pacing Study Group. Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. Heart Rhythm May 2017; 14(5): 685-691.
Prasad A, Sohn A, Morales J, Williams K, Bailey SR, Levin D, McCullough PA, Mehran R, Lopez-Cruz G, Harder J. Contemporary Practice Pattern Related to the Risk of Acute Kidney Injury in the Catherization Laboratory: Results from a Survey of Society of Cardiovascular Angiography and Intervention (SCAI) Cardiologists. Catherization Cardiovascular Interventions Feb 2017; 89(3): 383-392.
Raza FS, Grayburn PA, Choi JW. Use of MitraClip for severe mitral regurgitation in a cardiac transplant patient . Proceedings Baylor University Medical Center Apr 2017; 30 (2): 226-227.
Rich JD, Gosev I, Patel CB, Joseph S, Katz JN, Eckman PM, Lee S, Sundareswaran K, Kilic A, Bethea B, Soleimani B, Lima B, Uriel N, Kiernan M, Evolving Mechanical Support Research Group (EMERG) Investigators. The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. The Journal of Heart and Lung Transplantation Jan 2017; 36(1): 50-58.
Roberts WC, Grayburn PA, Guileyardo JM, Stoler RC. Full Development of Consequences of Congenital Pulmonic Stenosis in Eighty-Four Years . The American Journal of Cardiology Apr 2017; 119(8): 1284-1287.
Roberts WC, Grayburn PA, Hamman BL. Lipoma of the Mitral Valve. The American Journal of Cardiology Apr 2017; 119(7): 1121- 1123.
Roberts WC, Kapoor P, Main ML, Guileyardo JM. Acute Aortic Dissection with Intussusception of the Partition between the True and False Channels Leading to Near Total Aortic Occlusion (True Aortic Stenosis). American Journal of Cardiology Jan 2017; 119(2): 340-344.
Roberts WC, Sherwood M, Grayburn PA. Two causes for one patient for extremely low voltage on the electrocardiogram. Proceedings Baylor University Medical Center Apr 2017; 30(2): 228-229.
Roberts WC. Good Books Received in Cardiovascular Disease in 2016. The American Journal of Cardiology Feb 2017; S0002-9149(17)30186-30188.
Rogers JD, Sanders P, Piokowski C, Sohail MR, Anand R, Crossen K, Khairallah FS, Kaplon RE, Stromberg K, Kowal RC. In-office insertion of a miniaturized insertable cardiac monitor: Results from the Reveal LINQ In-Office 2 randomized study. Heart Rhythm Feb 2017; 14(2): 218-224.
Sannino A, Schiattarella GG, Toscano E, Gargiulo G, Giugliano G, Galderisi M, Losi MA, Stabile E, Cirillo P, Imbriaco M, Grayburn PA, Trimarco B, Esposito G. Meta-Analysis Effect of Body Mass Index on Outcomes after Transcatheter Aortic Valve Implantation. American Journal of Cardiology Jan 2017; 119(2): 308-316.
Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJV, Solomon SD. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial . The Lancet Diabetes & Endocrinology May 2017; 5(5): 333-340.
Sheikh IN, Roberts WC. Relation of left ventricular free wall rupture and/or aneurysm with acute myocardial infarction in patients with aortic stenosis . Proceedings Baylor University Medical Center Apr 2017; 30(2): 161-162.
Singer AJ, Than MP, Smith S, McCullough P, Barrett TW, Birkhahn R, Reed M, Thode HC, Arnold WD, Daniels LB, de Filippi C, Headden G, Peacock WF. Missed myocardial infarctions in ED patients prospectively categorized as low risk by established risk scores . American Journal of Emergency Medicine Jan 2017; Epub.
Solomon SD, Rizkala AR, Gong J, Wang W, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M , Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Shi VC, Lefkowitz MP, McMurray JJV. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. JACC Heart Failure 2017 Jul;5(7):471-482; Epub 2017 Jun 26.
Solomon TR, DeJong S, Bilbrey T, Carbone P , Campbell M, Parker RD, Kira A, Amarante D, Schussler JR, Adams J. Cardiac rehabilitation for a skydiver after aortic valve replacement for pure aortic regurgitation and resection of the ascending aorta complicated by active infective endocarditis and heart block requiring a pacemaker. Proceedings Baylor University Medical Center Apr 2017; 30(2): 234-236.
Tecson KM , Arnold W, Barrett T, Birkhahn R, Daniels LB, DeFilippi C, Headden G, Peacock WF, Reed M, Singer AJ, Schussler JM, Smith S, Than MP, McCullough PA. Interpretation of positive troponin results among patients with and without myocardial infarction. Proceedings Baylor University Medical Center Jan 2017; 30(1): 11-15.
Tecson KM, Panettiere-Kennedy KS, Won JI, Garg P, Olugbode O, McCullough PA. Relation between proprotein convertase subtilisin/kexin type 9 and directly measured low-density lipoprotein cholesterol. Proceedings Baylor University Medical Center Jan 2017; 30(1): 16-20.
Vasudevan A, Bottiglieri T, Tecson KM, Sathyamoorthy M, Schussler JM, Velasco CE, Lopez LR, Swift C, Peterson M, Bennett-Firmin J, Schiffmann R, McCullough PA. Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease . Coronary Artery Disease 2017 Jun;28(4):287-293.
Vasudevan A, Jazi HH, Won JI, Ball T, Patankar GR, Sarmast SA, Shin HJ, McCullough PA. Personalized treatment of heart failure with biomarker guidance using a novel disease severity score . Proceedings Baylor University Medical Center Apr 2017; 30(2): 139-142.
Vasudevan A, Munkres AG, Bottiglieri T, Won JI, Garg P, McCullough PA. Computation of a cardiac severity score with left-censored biomarkers for patients with heart failure . Pathology and Laboratory Medicine International Feb 2017; 9:15-20.
Vasudevan A, Munkres AG, Shin HJ, Sarmast SA, McCullough PA . Integration of Cardiac Biomarkers into a Disease-Specific Score and Its Relation to Intensity of Medical Therapy . Heart Circ Mar 2017; 1(1): 005.
Vasudevan A, Singer AJ, DeFilippi C, Headeen G, Schussler JM, Daniels LB, Reed M, Than MP, Birkhahn R, Smith SW, Barrett TW, Arnold W, Peacock WF, McCullough PA. Renal Function and Scaled Troponin in Patients Presenting to the Emergency Department with Symptoms of Myocardial Infarction . American Journal of Nephrology Feb 2017; 45: 304-309.
Velasco C, Mateo J, Santos A, Mota-Cobian A, Herranz F, Pellico J, Mota RA, España S, Ruiz-Cabello J. Assessment of regional pulmonary blood flow using 68Ga-DOTA PET . EJNMMI Res. 2017 Dec;7(1):7. Epub 2017 Jan 18.
Velasco CE, Howard C . Trouble on Both Sides: Pulmonary Embolism with Pneumothorax. The American Journal of Medicine May 2017; 130(5): 530-533.
Wilson G, Barkley K, Slicker K, Kowal R, Pope B, Michel J. Overuse of troponin? A comprehensive evaluation of testing in a large hospital system . Journal of Hospital Medicine May 2017; 12(5): 329-331.
Won JI, Zhang J, Tecson KM, McCullough PA. Balancing Low-density Lipoprotein Cholesterol Reduction and Hepatotoxicity with Lomitapide Mesylate and Mipomersen in Patients with Homozygous familial Hypercholesterolemia . Reviews in Cardiovascular Medicine 2017; 18(1): 21-28.
Zaman JAB, Baykaner T, Clopton P, Swarup V, Kowal RC, Daubert JP, Day JD, Hummel J, Schricker AA, Krummen DE, Mansour M, Tomassoni GF, Wheelan KR, Vishwanathan M, Park S, Wang PJ, Narayan SM, Miller JM. Recurrent Post-Ablation Paroxysmal Atrial Fibrillation Shares Substrates with Persistent Atrial Fibrillation: An 11-Center Study . JACC Clinical Electrophysiology Apr 2017; 3(4): 393-402.
Zhang J, Bottiglieri T, McCullough PA. The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome. Cardiorenal Medicine Feb 2017; 7(2): 104-117.
Zhrebker L , Cherni I , Gross LM , Hinshelwood MM , Reese M , Aldrich J , Guileyardo JM , Roberts WC , Craig D , Von Hoff DD, Mennel RG , Carpten JD . Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies . BMC Cancer Jan 2017; 17(1): 17.
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ. Recommendations for Noninvasive evaluation of native valvular regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography Apr 2017; 30(4): 303-371.
Jeffrey M. Schussler, MD, Anupama Vasudevan, BDS, MPH, PhD, Liana J. von Bose, BA, Jane I. Won, BS, Peter A. McCullough, MD, MPH
Transradial artery (TRA) approach is associated with fewer vascular complications and reduced mortality in patients at high risk compared with transfemoral approach (TFA). The objective of our study was to compare the characteristics and outcomes of patients who had coronary angiography by TRA and TFA over the course of hospital implementation of this approach.
Peter A McCullough, MD, MPH, Aasim Afzal, MD, MBA, Parag Kale, MD
Investigators have long recognized that renal function and cardiac performance are integrally linked through hemodynamic, neural, humoral, cell signaling, proteomic, and metabolomic pathways (1). Among risk factors for the development of heart failure (HF), chronic kidney disease (CKD) is the most powerful because it contributes to the three fundamental mechanisms of left ventricular failure: 1) pressure overload; 2) volume overload; and 3) cardiomyopathy (2). When CKD progresses to end-stage renal disease (ESRD), these three mechanisms driving HF become more difficult to control because patients undergoing dialysis have on average higher blood pressures; poor volume control only partially addressed by thrice weekly hemodialysis in most cases; and a well-described form of cardiomyopathy characterized by severe left ventricular hypertrophy, marked cardiac fibrosis, reduced capillary density, and calcific deposits on the mitral and aortic valves (3). None of the goal-directed medical or device therapies proven to reduce HF-related hospitalization and cardiovascular death in the general population with HF have been demonstrated to be effective in patients with ESRD (4).
Chad M. Dugas, MD and Jeffrey M. Schussler, MD, FACC, FSCAI
Improving the treatment of patients with cardiovascular disease as well as the safety of the physicians who care for them can potentially be impacted by several new technologies including high-resolution CT coronary imaging with fractional flow reserve, virtual reality, vascular robotic systems, and three-dimensional printing.
Jun Zhang, MD, MS, Jong Mi Ko, BA, Joseph M. Guileyardo, MD, and
William C. Roberts, MD
Spontaneous closure of VSD can be determined through a variety of methods — echocardiography, Doppler color flow imaging, angiography, auscultation, and cardiac catheterization — and can be proven by pathological evidence at necropsy.
William C. Roberts, MD, Kendall H. Burks, Jong Mi Ko, BA, Giovanni Filardo, PhD and Joseph M. Guileyardo, MD
Mortality rates during acute myocardial infarction (AMI) continue to drop, however, cardiac rupture (left ventricular free wall or ventricular septum or papillary muscular or combination) continues to remain relatively common. The aim of this study was to identify commonalities among patients with AMI complicated by cardiac rupture.
Sanjay Shrestha, BS, Jenny Adams, PhD, Anne Lawrence, RN, and Jeffrey M. Schussler, MD
A 64-year-old commercial pilot underwent elective percutaneous coronary intervention, and was then sent to cardiac rehabilitation. He wanted to maintain his rigorous strength and conditioning training and eventually return to being a pilot. A specialized training regimen was designed specifically for his needs, and he was able to resume his life as a commercial pilot.
Jenny Adams, PhD, Ana Lotshaw, PT, PhD, CCS, Emelia Exum, PT, DPT, Mark Campbell, BSc, MSc, Cathy B. Spranger, DrPH, Jim Beveridge, RN, PCCN, Shawn Baker, PT, DPT, MS, Stephanie McCray, RN, Tim Bilbrey, MBA, Tiffany Shock, BS, Anne Lawrence, RN, Baron L. Hamman, MD, Jeffrey M. Schussler, MD
Traditional sternal precautions, given to sternotomy patients as part of their discharge education, are intended to help prevent sternal wound complications. Our research team performed a series of studies that measured the forces exerted during various common activities and their relationship to the sternum. The alternative approach that we introduce applies standard kinesiological principles and teaches patients how to perform load-bearing movements in a way that avoids excessive stress to the sternum.
Barry J. Maron, MD, Henry L. Weiner, MD, Martin S. Maron, MD, William C. Roberts, MD
This publication discusses a 38 year old patient that presented with all three major disease complications of hypertrophic cardiomyopathy and survived as a result of effective treatment modalities available for individuals with the disease.
Wilber Su, MD, FHRS, Robert Kowal, MD, FHRS, Marcin Kowalski, MD, FHRS, Andreas Metzner, MD, FHRS, J. Thomas Svinarich, MD, FHRS, Kevin Wheelan, MD, FHRS, Paul Wang, MD, FHRS
This study reviews existing best practices regarding cryoballoon ablation in atrial fibrillation to create a user's consensus guide, providing insight into safer and more effective outcomes for CB2 ablations.
Danielle Armstrong, DO, Gonzalo V. Gonzalez-Stawinski, MD, Jong M. Ko, BA, Shelley A. Hall, MD, and William C. Roberts, MD
This article contains the clinical and morphologic findings in two patients who underwent heart transplantation because of severe heart failure as a result of cardiac sarcoidosis.
Jeffrey M. Schussler, Theodore T. Theologes, Baron L. Hamman
Peter A. McCullough, Poorya Fazel, James W. Choi.
Katherine Kane, Tammy Fisher, Monica Bennett, William Shutze Jr, Taylor Hicks, Brad Grimsley, Dennis Gable, Greg Pearl, Bert Smith, and William Shutze Sr, Dallas, Texas
Timothy D. Henry, Jay H. Traverse, Baron L. Hammon, Cara A. East, Brian Bruckner, Ann E. Remmers, David Recker, David A. Bull, Amit N. Patel.
Chad M. Dugas, MD and Jeffrey M. Schussler, MD, FACC, FSCAI
Improving the treatment of patients with cardiovascular disease as well as the safety of the physicians who care for them can potentially be impacted by several new technologies including high-resolution CT coronary imaging with fractional flow reserve, virtual reality, vascular robotic systems, and three-dimensional printing.
Beteck B, Shutze W, Richardson B, Shutze R, Tran K, Dao A, Ogola GO, Pearl G. Comparison of Athletes and Nonathletes Undergoing Thoracic Outlet Decompression for Neurogenic Thoracic Outlet Syndrome. Annals of Vascular Surgery January 2019; 54: 269-275.
Eidt JF. Duty Hours are Frequently Inaccurate. Journal of Vascular Surgery May 2019; 69(5): 1580.
Ewing MJ, Eidt JF. Con: Contrast-induced nephropathy-should we try to avoid contrast media in patients with chronic kidney disease? Nephrol Dial Transplant August 2018; 33(8): 1320-1322.
McCallum JC, Wyers MC, Soden PA, Eidt JF, Guzman RJ, Schermerhorn MD, Chaikof EL, Hamdan AD. Vascular fellow and resident experience performing infrapopliteal revascularization with endovascular procedures and vein bypass during training. Journal of Vascular Surgery November 2018; 68(5): 1533-1537.
Baumgarten H, Squiers JJ, Brinkman WT, Vasquez J Jr. Endovascular Technique for Repair of Descending Thoracic Aortic Aneurysm After Coarctation Operation. Annals Thoracic Surgery February 2017 103(2).
Parsa P, Cantu K, Eidt J, Gable D, Pearl G. Case Report: A Durable Open Repair of a Rare Profunda Aneurysm. Annals Vascular Surgery October 2017; 44: 424.e7-424.
Parsa P, Eidt J, Rios A, Gabble D, Vasquez, J Jr. Case Report An Innovative Endovascular Technique for Repair of Descending Thoracic Aortic Aneurysm following an Open Coarctation Repair. Annals Vascular Surgery January 2018;46:205.
Rios A, Parsa P, Eidt J, Pearl G. A novel surgical approach to symptomatic left renal vein aneurysm. Journal of Vascular Surgery November 2017; 5(6):875-877.
Thompson RW, Dawkins C, Vemuri C, Mulholland MW, Hadzinsky TD, Pearl GJ. Performance Metrics in Professional Baseball Pitchers before and after Surgical Treatment for Neurogenic Thoracic Outlet Syndrome. Annals Vascular Surgery February 2017; 39:216-227.
William S, Richardson B, Shutze R, Tran K, Dao A, Ogola GO, Young A, Pearl G Midterm and long-term follow-up in competitive athletes undergoing thoracic outlet decompression for neurogenic thoracic outlet syndrome. Journal of Vascular Surgery December 2017; 66(6):1798-1805.
Young A, Kastner L, Vasquez J Jr. Novel technique of selective stent deployment in complicated thoracic aortic aneurysm. Proceedings Baylor University Medical Center July 2017: 30(3).
Parsa P, Eidt J , Rios A, Gable D, Vasquez J Jr. Case Report: An Innovative Endovascular Technique for Repair of Descending Thoracic Aortic Aneurysm following an Open Coarctation Repair. Annals of Vascular Surgery . 2017 May 4.
Parsa P, Rios A, Cantu K, Eidt J , Gable D, Pearl G. Case Report: A Durable Open Repair Of A Rare Profunda Aneurysm . Annals of Vascular Surgery . 2017 Jun 7.
Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criterial for Coronary Revascularization in Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. Journal of the American College of Cardiology May 2017; 69(17): 2212-2241.
Thompson RW, Dawkins C, Vemuri C, Mulholland MW, Hadzinsky TD, Pearl GJ . Performance Metrics in Professional Baseball Pitchers before and after Surgical Treatment for Neurogenic Thoracic Outlet Syndrome. Annals of Vascular Surgery. 2017 Feb;39:216-227; Epub 2016 Aug 12.
Young A, Kastner L, Vasquez J , Jr. Novel technique of selective stent deployment in complicated thoracic and aortic aneurysm. Proceedings Baylor University Medical Center Jul 2017; 30(3): 298-300.
Please click the "Continue Session" button below to continue using the website. To end your session please click the "End Session" button below. After 5 minutes of inactivity your session will be terminated and you will be required to log in again.